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Received August 3, 2010; accepted August 11, 2011AbstractA 67-year-old man was examined for persistent pain over his lower abdomen and was found to have a large pelvic tumor. During surgery, we
detected a 16  9  9 cm3 urinary bladder tumor with small intestinal adhesions, and performed partial cystectomy and segmental resection.
Histological and immunohistochemical examinations established the diagnosis of malignant solitary fibrous tumor (SFT). Only 10 cases of
urinary bladder SFT have been reported in the English literature; our patient is the second one with malignancy and had a longer follow-up
period than the other case.
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Solitary fibrous tumor (SFT) is a rare type of mesenchymal
tumor. In the past, SFT was thought to be a pleural-based
lesion; however, it has recently been reported to occur in
many extrapleural sites with no mesothelial lining.1e5 SFTs
are usually benign and slow growing, but malignant SFTs have
been described to have a greater potential of recurrence or
metastasis. Extrapleural SFTs of the urinary bladder are
extremely rare, and only 10 cases have been reported in the
English literature.6 Of these cases, only one showed malignant
pathological feature.3 In this study, we present the second case
of a patient with a malignant SFT.
2. Case report
A 67-year-old man had noticed a palpable mass in his right
lower abdomen for 2 years. One month prior to admission,
he felt pain during exercise and visited a hospital. Physical* Corresponding author. Dr. Shian-Shiang Wang, Division of Urology,
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Chung-Kang Road, Taichung 407, Taiwan, ROC.
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http://dx.doi.org/10.1016/j.jcma.2012.06.021examination showed a movable firm mass over the right lower
abdomen. Urinary analysis revealed microscopic hematuria,
and urinary cytologywas negative for urothelial carcinoma. The
tumor markers including prostate specific antigen (PSA), alpha-
fetoprotein (AFP), carbohydrate antigen (CA)-125, CA-153,
carcinoembryonic antigen (CEA), and CA-19-9 were all within
normal limit. Abdominal magnetic resonance imaging (MRI)
showed a large soft-tissue mass, with the highest diameter being
16 cm, arising from the dome of the urinary bladder (Fig. 1).
During surgery, we found that the tumor was adhered firmly
to the small intestine. In addition, multiple engorged vessels
extended from the urinary bladder to the tumor. We performed
partial cystectomy and segmental resection of the intestine.
The postoperative recovery course was uneventful. The patient
has been well after an 18-month follow-up.
The mass was an encapsulated gray-white tumor, measuring
16  9  9 cm3 (Fig. 2). The transection was white and multi-
nodular, with a 4  4  3 cm3 necrotic defect. Microscopic
examination revealed that the tumor was composed of ovoid- to
spindle-shaped cells. The tumor showed merged hyper- and
hypocellular zones in short fascicular arrangement, and spiral to
random patterns (patternless pattern). We observed bundles of
collagen and sclerosing stromal cells scattered between tumor
cells.We also observed branching and hemangiopericytoma-likehinese Medical Association. All rights reserved.
Fig. 1. (A) Parasagittal and (B) coronal MRI (T2-weighted) of the pelvis
revealed a large lobulated soft-tissue solid tumor. The hyperintense cystic
components (arrow) were considered to indicate areas of central necrosis.
Fig. 3. (A) Tumor exhibits high cellularity and is composed of spindle to oval
cells arranged in short, ill-defined fascicles with nuclear atypia and three
mitoses, staghorn vessels, and interstitial hyalinization (H&E stain, 400). (B)
Tumor cells exhibit diffuse positivity for CD34 (immunohistochemical stain,
100). H&E ¼ hematoxylin and eosin.
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tumor, mitotic activity >4 mitoses/10 high-power field (HPF)
(Fig. 3A), and cellular atypia in local region indicated the
malignancy of the tumor. Immunohistochemical examination
revealed that the tumor cells were strongly positive for CD34
(Fig. 3B) and CD99, but negative for CD117, smooth muscle
actin, and AE1/AE3.3. Discussion
Ten cases of SFT of the urinary bladder have been reported
in the English literature, and only one of them was malignant
(Table 1).3,6e12 The long-term outcome of that malignantFig. 2. The tumor was 16  9  9 cm3 in size and invaded the small intestine
(arrow).tumor is unknown. Tumor most often occurs in 50e60-year-
old adults,1 and its common clinical manifestations are pain
and palpable mass. Hematuria and dysuria are less common,
but have also been reported. Symptomatic hypoglycemia is
associated with the secretion of insulin-like growth factor-2
and was rarely observed in patients with SFTs of the urinary
bladder.10
Appearance of SFTs does not have a specific pattern. It
often appears as a well-circumscribed, highly vascular mass
without any invasion of nearby structures. MRI revealed that
the mass was often isointense or hypointense on T1-weighted
images (T1WI) and heterogeneous on T2WI. The heteroge-
neous appearance may be attributed to variation in cellular and
collagenous content. Very low T2 signal regions may be
observed and were attributed to the presence of interstitium
rich with collagen and fibrotic tissue.13 In our case, iso-
intensity of the mass in T1WI and heterogeneity in both T1WI
and T2WI were consistent with the typical findings of SFTs.
The tumor was well enhanced after contrast injection, which
also fits with the hypervascular nature of the SFT. The central
necrosis pattern observed in our case also indicated
malignancy.
Histologically, SFTs are characterized by a branching
hemangiopericytoma-like vasculature, usually with peri-
vascular hyalinization. Spindle-shaped, monomorphic fibro-
blasts between collagen bundles are a common presentation.
Variation in cellularity, with random distribution of hyper- and
Table 1
Clinical data of the reported 10 cases of solitary fibrous tumor of the urinary bladder.
Case no. Authors (reference) Age/sex Presentation Size (cm) Benign/malignant Treatment Follow-up (mo)
1 Heinzelbecker et al6 24/F Gross hematuria, lower
abdominal pain
8.5  7.8 Benign TURBT þ partial
cystectomy
24
2 Tzelepi et al7 59/F Intermittent hematuria 8.5  6.5  4.5 Benign Radical cystectomy 77
3 Leite et al8 60/M Incidental MRI finding for
prostate cancer
3.2 Benign Radical
prostatectomy þ complete
tumor excision
11
4 Kim et al9 56/M Urinary frequency and
residual urine sensation
12  8  6 Benign Wide excision 12
5 Corti et al10 50/M Pelvic pain, dysuria,
hematuria
6.5 Benign Total cystectomy 18
6 Westra et al3 67/M Incidental cystoscopic
finding during TURP
4 Malignant Cystoprostatectomy 9
7 Westra et al3 67/M Incidental MRI finding for
prostate cancer
? Benign TURBT 1
8 Bainbridge et al11 50/F Incidental US finding for
perforated colon
diverticulum
5.2  4.4  4.3 Benign TURBT 18
9 Bainbridge et al11 42/M Pelvic pressure 17  13.5  15.5 Benign Wide excision 3
10 Ishikawa et al12 64/M Difficult voiding and
constipation
12.5  9.5  8.3 Benign Wide excision 3
MRI ¼ magnetic resonance imaging; TURBT ¼ transurethral resection of bladder tumor; TURP ¼ transurethral resection of prostate; US ¼ ultrasonographic.
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architecture.1,2 Mitosis and necrosis are relatively rare in
SFTs.1,2 The criteria for malignancy include large tumor size
(>10 cm), hypercellularity, nuclear pleomorphism, tumor
necrosis, >4 mitoses/10 HPF, and infiltrative margins.2,14
However, SFTs can have variable morphologies. Therefore,
immunohistochemical staining plays an important role in the
diagnosis. The tumor cells are often positive for CD34, CD99,
and bcl-2, but they are negative for S-100 protein, actin,
desmin, and keratin.1e6,10 We observed diffuse expression of
CD34 and CD99 in our patient.
Gastrointestinal stromal tumor (GIST) is another condition
considered in differential diagnosis, because the histological
appearance of GIST is similar to that of SFTs, and GIST may
also be positive for CD34 and bcl-2. However, GIST is often
positive for CD117. Smooth muscle tumor cells have cigar-
shaped nuclei, perinuclear vacuoles, and eosinophilic cyto-
plasm. While some smooth muscle tumor cells were positive
for CD34, almost all cells were positive for smooth muscle
actin. The tumor cells were negative for cytokeratin AE1/AE3
antigen, which is a specific marker for epithelium-derived
tumor; this finding ruled out the possibility of a carcinoma.
The spindle-shaped cells of the tumor originating from the
nerve sheath have a special comma-shaped nucleus, and these
cells are negative for CD34 and bcl-2 and positive for S-100
protein.1,2,10 We diagnosed SFT on the basis of the results of
morphological and immunohistochemical examinations.
Further, this tumor fits the malignancy criteria: large tumor
size (16 cm), high cellularity, pleomorphism, six mitoses/10
HPF and up to three mitoses in an HPF (>4/10 HPF), necrosis,
and infiltrative border in the muscle of urinary bladder.
Although extrapleural SFTs with benign histology can also
show aggressive behavior, malignant SFTs account for higher
rates of local recurrence, metastasis, and mortality.15Complete resection of the tumor is the most recommended
treatment if available, and it has a favorable long-term survival
rate.1,16 Adjuvant radiation therapy can be considered in
selected patients, but the efficacy of this treatment remains
controversial. In contrast, patients with unresectable, recur-
rent, or metastatic SFT have a worse outcome. Radiation
therapy can be administered to these patients as an adjuvant
therapy or a primary therapy. Recently, antiangiogenic therapy
has been considered to be a promising treatment for these
patients, and, to date, sufficient evidence for systemic
chemotherapy has not been obtained.16
We performed partial cystectomy instead of radical cys-
tectomy because the tumor could be completely resected with
safe surgical margin and proper residual bladder volume. No
adjuvant therapy was administered. The patient showed good
recovery and did not show local recurrence on the CT image
obtained after 18 months of follow-up. Thus, surgery seems to
be an appropriate treatment modality for malignant SFT.
However, more clinical data and longer follow-ups are
required to evaluate the outcome of the disease.
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